XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

Overview
Date Founded

1993

Headquarters

85 Medinat Hayehudim St., Building G,Herzliya Business Park,Herzliya Pituach,Herzliya, Tel Aviv 46766

Type of Company

Public

Employees (Worldwide)

8

Industries

Pharmaceuticals
Biotechnology

Company Description

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Executives & Employees

Chief Executive Officer

Chief Executive Officer & Executive Director

Chief Financial Officer

Co-Founder

Medical Director

Vice President, Regulatory Affairs

Board of Directors

Chief Executive Officer at Internet Gold Golden Lines Ltd.

Chief Executive Officer & Executive Director at XTL Biopharmaceuticals Ltd.

Former Chief Executive Officer at Intervision, Inc.

Former Chief Financial Officer at Haldor Advanced Technologies Ltd.

HIV Director-National Hemophilia Center at Sheba Medical Center

President & Director at Insight Biopharmaceuticals Ltd.

Director at Elron Electronic Industries Ltd.

Paths to XTL Biopharmaceuticals Ltd.
Potential Connections via
Relationship Science
You
XTL Biopharmaceuticals Ltd.
Recent Transactions
Details Hidden

XTL Biopharmaceuticals Ltd. raised money in a private placement transaction

Details Hidden

XTL Biopharmaceuticals Ltd. raised money in a private placement transaction

Details Hidden

Zmiha Investment House Ltd. purchases Cannomed Medical Cannabis Industries Ltd. from XTL Biopharmaceuticals Ltd.

Transaction Advisors
Legal Advisor

Advised onXTL Biopharmaceuticals Ltd. issued GBP Ordinary Shares

Underwriter

Advised onXTL Biopharmaceuticals Ltd. issued GBP Ordinary Shares

Investment Advisor

Advised onXTL Biopharmaceuticals Ltd. raised money in a private placement transaction

Advisors & Consultants
Scientific Advisor

Associate Director, Rheumatology Fellowship Program at Cedars-Sinai Medical Center

Scientific Advisor
Scientific Advisor

Director, Lupus Clinic at Toronto Western Hospital

Key Stats and Financials As of 2020
Market Capitalization
$22.1M
Total Enterprise Value
$8.97M
Earnings Per Share
$0
Net Profit
$-779K
EBITDA
$-943K
Total Debt
$0
Total Equity
$5.81M
Revenue
$0
Three Year Compounded Annual Growth Rate Of Revenue
0%
Debt TEV
0x
TEVNet Income
-11.52x
Investors
Details Hidden

Managing Partner at Ourcrowd Pandemic Innovation Fund at OurCrowd Management Ltd.

Details Hidden

Lab-One is an active manager which initiates, invests and builds up Israeli-based seed-stage technology ventures, focusing on companies in the ICT sector including advanced telecom technology, converged networking, mobile datacom, mobile technology, internet technology, Web2.0 enabling technology, broadband & multimedia, cellular infrastructure, fabless semiconductor and storage & IT infrastructure.The firm prefers to participate in the first round of financing or at the foundation round of a start-up, typically investing USD 0.5-1.0 million initially and additional amounts in subsequent rounds.Lab-One seeks to invest in early-stage Israeli-based pre-seed companies with committed, motivated, and knowledgeable management, a technology with broad commercial application that addresses a large and growing market, an innovative, patentable technology, the capacity and ability to reach significant milestones within two years and which are eligible for the Office of the Chief Scientist incubator program.

Details Hidden

Lombard Odier Japan is an active manager focused on capital preservation over the long term. They tailor their services to their clients'' profiles and shares research and management with Lombard Odier offices worldwide. The parent bank's investment approach is research-driven and combines a top-down view with a bottom-up security selection process. Research is shared globally.The firm's investment strategy team elaborates and continuously updates macroeconomic forecasts and investment scenarios based on quantitative and technical analysis, resulting in geographical, sectoral and currency allocations. The buyside equity research team tracks a predefined universe of companies worldwide. They also identify promising sectors, regions and themes, assisted by the quantitative research team. The group has specific expertise in private equity investments.Lombard Odier Japan invests primarily in Japanese equity and debt. Equity investments are based on macro analysis and are held over the long term. Stock selection focuses on growth potential, cash-flow history, comparative earnings, balance sheet soundness, management track record with evidence of a cohesive business strategy and market position. Fixed-income investments are based on a combination of macro and market analysis which seeks to identify relative value within and across markets. Portfolio management teams are small and specialized, and use a shared investment platform common to all research and investment teams within Lombard Odier.

Suppliers
Weizmann Institute of Science Schools & Student Services | Rehovot, Israel

The Weizmann Institute of Science is one of the world’s leading multidisciplinary research institutions. Hundreds of scientists, laboratory technicians and research students working on its lushly landscaped campus embark daily on fascinating journeys into the unknown, seeking to improve our understanding of nature and our place within it. Lettuce fieldGuiding these scientists is the spirit of inquiry so characteristic of the human race. It is this spirit that propelled humans upward along the evolutionary ladder, helping them reach their utmost heights. It prompted humankind to pursue agriculture, learn to build lodgings, invent writing, harness electricity to power emerging technologies, observe distant galaxies, design drugs to combat various diseases, develop new materials and decipher the genetic code embedded in all the plants and animals on Earth. The quest to maintain this increasing momentum compels Weizmann Institute scientists to seek out places that have not yet been reached by the human mind. What awaits us in these places? No one has the answer to this question. But one thing is certain – the journey fired by curiosity will lead onward to a better future. Groundbreaking medical and technological applications that have emerged from basic research conducted by Weizmann Institute scientists include: Amniocentesis, a prenatal diagnostic test for the fetus neonatal Sophisticated laser systems for high-precision diamond cutting A method for growing hybrid seeds that prevents the transmission of disease from one generation to the next and helps protect edible plants from pests Affinity chromatography, a key tool for purifying biological materials in the biotechnology industry Living polymerization, one of the most fundamental techniques of the modern polymer industry For solving the structure of the ribosome, the cell’s protein factory, and revealing its means of action, the Institute’s Prof. Ada Yonath was awarded a Nobel Prize in Chemistry. Her research should speed the development of antibiotic drugs that are more efficient, especially against antibiotic-resistant strains

Clalit Health Services Medical Support Services | Tel Aviv, Israel

Clalit Health Services Group provides healthcare services. The firm provides general and specialized hospitals with emergency rooms, outpatient departments, day care centers, clinical pathology laboratories, and imaging departments, which include X-ray, ultrasound, CT, and MRI facilities. The company was founded in 1911 and is headquartered in Tel Aviv, Israel.

Ligand Pharmaceuticals, Inc. Medical Support Services | La Jolla, CA

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by XTL Biopharmaceuticals Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of XTL Biopharmaceuticals Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and XTL Biopharmaceuticals Ltd..